{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:31:01Z","timestamp":1777113061144,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["256431"],"award-info":[{"award-number":["256431"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2011016"],"award-info":[{"award-number":["2011016"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Central nervous system depressant medications (CNSDs) such as opioid analgesics and sedative-hypnotics are commonly prescribed to older patients for the treatment of chronic pain, anxiety and insomnia. Yet, while many studies reported potential harms, it remains unknown whether persistent use of these medications is beneficial for older patients\u2019 self-reported health-related quality of life (HRQoL). The present study clarified this knowledge gap through comparing HRQoL of hospitalized older patients with versus without using CNSD drugs for \u22654\u2009weeks. Moreover, we explored the relationship between such use and HRQoL, adjusting for the effects of polypharmacy, comorbidity burden and other clinically relevant covariates.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The study was cross-sectional and included 246 older patients recruited consecutively from somatic departments of a large regional university hospital in Norway. We defined prolonged CNSD use as using opioids, benzodiazepines and\/or z-hypnotics for \u22654\u2009weeks. Patients\u2019 self-reported HRQoL were measured with scales of the EuroQol EQ-5D-3L instrument. Data analyses were mainly descriptive statistics and regression models.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Patients with prolonged use of CNSDs reported lower scores on both EQ-5D index and EQ VAS compared with those without such use (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). They had higher odds of having more problems performing usual activities (OR\u2009=\u20093.37, 95% CI: 1.40 to 8.13), pain\/discomfort (OR\u2009=\u20092.06, 95% CI: 1.05 to 4.04), and anxiety\/depression (OR\u2009=\u20093.77, 95% CI: 1.82 to 7.82).<\/jats:p>\n<jats:p>In multivariable regression models, there was no significant association between prolonged CNSD use and HRQoL when including pain as a predictor variable. In models not including pain, CNSD use was strongly associated with HRQoL (adjusted for sociodemographic background, polypharmacy, comorbidity, anxiety and depressive symptoms, regression coefficient\u2009\u2212\u20090.19 (95% CI, \u2212\u20090.31 to \u2212\u20090.06).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Older patients with prolonged CNSD use reported poorer HRQoL. They also had more pain and higher depression scores. Prolonged use of CNSDs was not independently associated with higher HRQoL.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12877-020-01838-8","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T09:02:36Z","timestamp":1603443756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Health-related quality of life in hospitalized older patients with versus without prolonged use of opioid analgesics, benzodiazepines, and z-hypnotics: a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-7585","authenticated-orcid":false,"given":"Socheat","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahreem Ghazal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Stavem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen Saxhaug","family":"Kristoffersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christofer","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"issue":"7","key":"1838_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics. 2016;34(7):645\u20139.","journal-title":"PharmacoEconomics."},{"issue":"1","key":"1838_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cger.2010.08.006","volume":"27","author":"NS Fedarko","year":"2011","unstructured":"Fedarko NS. The biology of aging and frailty. Clin Geriatr Med. 2011;27(1):27\u201337.","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"1838_CR3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WAD.0000000000000262","volume":"32","author":"SD Stites","year":"2018","unstructured":"Stites SD, Harkins K, Rubright JD, Karlawish J. Relationships between cognitive complaints and quality of life in older adults with mild cognitive impairment, mild Alzheimer disease dementia, and normal cognition. Alzheimer Dis Assoc Disord. 2018;32(4):276\u201383.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"1838_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1471-244X-13-249","volume":"13","author":"J Atkins","year":"2013","unstructured":"Atkins J, Naismith SL, Luscombe GM, Hickie IB. Psychological distress and quality of life in older persons: relative contributions of fixed and modifiable risk factors. BMC psychiatry. 2013;13(1):249.","journal-title":"BMC psychiatry."},{"issue":"1","key":"1838_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1477-7525-9-95","volume":"9","author":"IN Olsson","year":"2011","unstructured":"Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9(1):95.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"1838_CR6","doi-asserted-by":"publisher","first-page":"zsy125","DOI":"10.1093\/sleep\/zsy125","volume":"41","author":"GL Dunietz","year":"2018","unstructured":"Dunietz GL, Swanson LM, Jansen EC, Chervin RD, O\u2019Brien LM, Lisabeth LD, et al. Key insomnia symptoms and incident pain in older adults: direct and mediated pathways through depression and anxiety. Sleep. 2018;41(9):zsy125.","journal-title":"Sleep"},{"key":"1838_CR7","volume-title":"Lexicon of alcohol and drug terms","author":"World Health Organization","year":"1994","unstructured":"World Health Organization. Lexicon of alcohol and drug terms. Geneva: World Health Organization; 1994."},{"issue":"7","key":"1838_CR8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1532-5415.2010.02920.x","volume":"58","author":"M Papaleontiou","year":"2010","unstructured":"Papaleontiou M, Henderson J, Charles R, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2010;58(7):1353\u201369.","journal-title":"J Am Geriatr Soc"},{"issue":"17","key":"1838_CR9","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1503\/cmaj.130025","volume":"185","author":"JM McMillan","year":"2013","unstructured":"McMillan JM, Aitken E, Holroyd-Leduc JM. Management of insomnia and long-term use of sedative-hypnotic drugs in older patients. CMAJ. 2013;185(17):1499\u2013505.","journal-title":"CMAJ."},{"issue":"9","key":"1838_CR10","doi-asserted-by":"publisher","first-page":"e031483","DOI":"10.1136\/bmjopen-2019-031483","volume":"9","author":"S Cheng","year":"2019","unstructured":"Cheng S, Siddiqui TG, Gossop M, Kristoffersen ES, Lundqvist C. Sociodemographic, clinical and pharmacological profiles of medication misuse and dependence in hospitalised older patients in Norway: a prospective cross-sectional study. BMJ Open. 2019;9(9):e031483.","journal-title":"BMJ Open"},{"issue":"6","key":"1838_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3949\/ccjm.83a.15023","volume":"83","author":"M Galicia-Castillo","year":"2016","unstructured":"Galicia-Castillo M. Opioids for persistent pain in older adults. Cleve Clin J Med. 2016;83(6):443\u201351.","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"1838_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs in R&D. 2017;17(4):493\u2013507.","journal-title":"Drugs in R&D"},{"issue":"1","key":"1838_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2318-9-20","volume":"9","author":"A Carlsten","year":"2009","unstructured":"Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009;9(1):20.","journal-title":"BMC Geriatr"},{"issue":"7","key":"1838_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11739-014-1124-1","volume":"9","author":"PM Mannucci","year":"2014","unstructured":"Mannucci PM, Nobili A, Investigators R. Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. Intern Emerg Med. 2014;9(7):723\u201334.","journal-title":"Intern Emerg Med"},{"issue":"1","key":"1838_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000109763","volume":"16","author":"J Karlawish","year":"2008","unstructured":"Karlawish J. Measuring decision-making capacity in cognitively impaired individuals. Neurosignals. 2008;16(1):91\u20138.","journal-title":"Neurosignals."},{"issue":"1","key":"1838_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R, Group E. EuroQol: the current state of play. Health policy. 1996;37(1):53\u201372.","journal-title":"Health policy"},{"issue":"S11","key":"1838_CR17","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1002\/acr.20543","volume":"63","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (vas pain), numeric rating scale for pain (nrs pain), mcgill pain questionnaire (mpq), short-form mcgill pain questionnaire (sf-mpq), chronic pain grade scale (cpgs), short form-36 bodily pain scale (sf-36 bps), and measure of intermittent and constant osteoarthritis pain (icoap). Arthritis Care Res. 2011;63(S11):S240\u2013S52.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"1838_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1838_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","volume":"41","author":"MD Miller","year":"1992","unstructured":"Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res. 1992;41(3):237\u201348.","journal-title":"Psychiatry Res"},{"issue":"9","key":"1838_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989\u201395.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1838_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/08039488.2011.560684","volume":"65","author":"A-S Helvik","year":"2011","unstructured":"Helvik A-S, Engedal K, Skancke RH, Selb\u00e6k G. A psychometric evaluation of the hospital anxiety and depression scale for the medically hospitalized elderly. Nordic J Psychiatry. 2011;65(5):338\u201344.","journal-title":"Nordic J Psychiatry"},{"issue":"1","key":"1838_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12955-017-0759-9","volume":"15","author":"I Djukanovic","year":"2017","unstructured":"Djukanovic I, Carlsson J, \u00c5restedt K. Is the hospital anxiety and depression scale (HADS) a valid measure in a general population 65\u201380 years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017;15(1):193.","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"1838_CR23","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/j.1532-5415.2008.01935.x","volume":"56","author":"F Salvi","year":"2008","unstructured":"Salvi F, Miller MD, Grilli A, Giorgi R, Towers AL, Morichi V, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc. 2008;56(10):1926\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"1838_CR24","unstructured":"Erkan A, Yildiz Z. Parallel lines assumption in ordinal logistic regression and analysis approaches. Int Interdisciplinary J Sci Res. 2014;1:10\u201311."},{"issue":"6","key":"1838_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/RHU.0000000000000735","volume":"24","author":"Y Hattori","year":"2018","unstructured":"Hattori Y, Katayama M, Kida D, Kaneko A. Hospital anxiety and depression scale score is an independent factor associated with the EuroQoL 5-dimensional descriptive system in patients with rheumatoid arthritis. J Clin Rheumatol. 2018;24(6):308\u201312.","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"1838_CR26","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106(12):2086\u2013109.","journal-title":"Addiction."},{"issue":"7","key":"1838_CR27","doi-asserted-by":"publisher","first-page":"e00688","DOI":"10.1016\/j.heliyon.2018.e00688","volume":"4","author":"M-M Tanguay Bernard","year":"2018","unstructured":"Tanguay Bernard M-M, Luc M, Carrier J-D, Fournier L, Duhoux A, C\u00f4t\u00e9 E, et al. Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon. 2018;4(7):e00688.","journal-title":"Heliyon"},{"issue":"1","key":"1838_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40360-017-0149-2","volume":"18","author":"P-J Samuelsen","year":"2017","unstructured":"Samuelsen P-J, Nielsen CS, Wilsgaard T, Stubhaug A, Svendsen K, Eggen AE. Pain sensitivity and analgesic use among 10,486 adults: the Troms\u00f8 study. BMC Pharmacol Toxicol. 2017;18(1):45.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"1838_CR29","first-page":"CD006605","volume":"2010","author":"M Noble","year":"2010","unstructured":"Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;2010(1):CD006605.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1838_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-244X-7-42","volume":"7","author":"DF Kripke","year":"2007","unstructured":"Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7(1):42.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"1838_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.addbeh.2012.05.017","volume":"37","author":"T Nordfj\u00e6rn","year":"2012","unstructured":"Nordfj\u00e6rn T. A population-based cohort study of anxiety, depression, sleep and alcohol outcomes among benzodiazepine and z-hypnotic users. Addict Behav. 2012;37(10):1151\u20137.","journal-title":"Addict Behav"},{"issue":"9","key":"1838_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","volume":"34","author":"MD Sullivan","year":"2018","unstructured":"Sullivan MD. Depression effects on long-term prescription opioid use, abuse, and addiction. Clin J Pain. 2018;34(9):878\u201384.","journal-title":"Clin J Pain"},{"issue":"11","key":"1838_CR33","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1097\/j.pain.0000000000000650","volume":"157","author":"B Halbert","year":"2016","unstructured":"Halbert B, Davis R, Wee CC. Disproportionate longer-term opioid use among US adults with mood disorders. Pain. 2016;157(11):2452.","journal-title":"Pain"},{"issue":"2","key":"1838_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1524-4733.2006.00162.x","volume":"10","author":"P Sobocki","year":"2007","unstructured":"Sobocki P, Ekman M, \u00c5gren H, Krakau I, Runeson B, M\u00e5rtensson B, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health. 2007;10(2):153\u201360.","journal-title":"Value Health"},{"issue":"10","key":"1838_CR35","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1185\/030079906X132622","volume":"22","author":"Y Ko","year":"2006","unstructured":"Ko Y, Coons SJ. Self-reported chronic conditions and EQ-5D index scores in the US adult population. Curr Med Res Opin. 2006;22(10):2065\u201371.","journal-title":"Curr Med Res Opin"},{"key":"1838_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2147\/PPA.S156713","volume":"12","author":"S Zhang","year":"2018","unstructured":"Zhang S, Meng L, Qiu F, Yang JD, Sun S. Medication-related risk factors associated with health-related quality of life among community-dwelling elderly in China. Patient Prefer Adherence. 2018;12:529\u201337.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"1838_CR37","doi-asserted-by":"publisher","first-page":"e0171320","DOI":"10.1371\/journal.pone.0171320","volume":"12","author":"A Montiel-Luque","year":"2017","unstructured":"Montiel-Luque A, N\u00fa\u00f1ez-Montenegro AJ, Martin-Aurioles E, Canca-S\u00e1nchez JC, Toro-Toro MC, Gonz\u00e1lez-Correa JA, et al. Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy. PLoS One. 2017;12(2):e0171320.","journal-title":"PLoS One"},{"key":"1838_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/JPR.S105892","volume":"9","author":"M Due\u00f1as","year":"2016","unstructured":"Due\u00f1as M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016;9:457.","journal-title":"J Pain Res"},{"issue":"2","key":"1838_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/2374373518786013","volume":"6","author":"MA Hadi","year":"2019","unstructured":"Hadi MA, McHugh GA, Closs SJ. Impact of chronic pain on patients\u2019 quality of life: a comparative mixed-methods study. J Patient Exp. 2019;6(2):133\u201341.","journal-title":"J Patient Exp"},{"issue":"7","key":"1838_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/papr.12533","volume":"17","author":"C P\u00e9rez","year":"2017","unstructured":"P\u00e9rez C, Margarit C, S\u00e1nchez-Magro I, de Antonio A, Villoria J. Chronic pain features relate to quality of life more than physiopathology: a cross-sectional evaluation in pain clinics. Pain Pract. 2017;17(7):866\u201378.","journal-title":"Pain Pract"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-020-01838-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-020-01838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T19:25:45Z","timestamp":1634930745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-020-01838-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1186\/s12877-020-01838-8","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Regional Committee for Medical Research Ethics \u2013 South East Norway (Reference number: 2016\/2289\/REK S\u00f8r-\u00d8st) and the Data Protection Office at Akershus University Hospital (Reference number: 17\u2013054). All participants provided written informed consents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CL reports having received research grants from the South-East Regional Health authority, during the conduct of the study as well as grants and personal fees from Abbvie pharma AS and Roche Norway AS, outside this submitted work. The agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Other authors declared no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"425"}}